Board Member @ CytoLynx Therapeutics (January 2021 - Present)
Scientific Advisory Board @ (January 2019 - January 2021)
Chief Development Officer @ (January 2018 - January 2020)
Board Member @ OliX US, Inc. (January 2018 - January 2020)
Executive Vice President @ Boston Biomedical (January 2012 - January 2018)
Vice President @ Boston Biomedical (January 2007 - January 2012)
Manager and Senior Investigator, In Vivo Center @ ArQule (January 2005 - January 2007)
Instructor @ (January 2004 - January 2005)
Research Fellow @ (January 2001 - January 2004)
Wei Li Education
Harvard Medical School
(Immunology)
Georgia State University
Doctor of Philosophy (Philosophy, Virology)
sun yat sen university
Bachelors (Biochemistry)
Wei Li Summary
Wei Li, based in Boston, MA, US, is currently a Chief Scientific Officer at Cytovia Therapeutics. Wei Li brings experience from previous roles at NAYA Biosciences, CytoLynx Therapeutics, Artus therapeutics and OliX Pharmaceuticals, Inc.. Wei Li holds a Harvard Medical School. Wei Li has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Wei Li?
Find contact details for 700 million professionals.